Gerado Rosati
Gerado Rosati publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes and Gastrointestinal Tumor Research and Treatment.
- World rank
- #6,543,847 of 7,710,434 ranked researchers
- Rank in Italy
- #214,161 of 242,206
- Works
- 17
- Citations
- 72
- Citations per work
- 4.2
What does Gerado Rosati research?
Gerado Rosati's work is mostly in Medicine (84%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1483.6%
- Medicine1483.6%
- Everything else210.3%
- Life Sciences16.1%
- 1Oncology37% of their works
- 2Pulmonary and Respiratory Medicine24% of their works
- 3Surgery12% of their works
- 4Gastroenterology6% of their works
- 5Cancer Research6% of their works
- 6Epidemiology4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Metastasis and carcinoma case studies
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
Which keywords describe Gerado Rosati's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Cetuximab, KRAS Mutations, Endoscopic Resection, Gastric Cancer, Neoadjuvant Therapy and Chemotherapy-Induced Peripheral Neuropathy.
- Pancreatic Cancer
- Cancer Genomics
- Sunitinib
- Preoperative Chemoradiotherapy
- Lung Tumors
- Chemotherapy-Induced Peripheral Neuropathy
- Gastric Cancer
- KRAS Mutations
- Clinical Practice Guidelines
- Chemotherapy
- Cetuximab
- Endoscopic Resection
- Neoadjuvant Therapy
- Imatinib Mesylate
- Metastatic Carcinomas
- Rectal Cancer
- Taxanes
- Mutational Signatures
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Chemotherapy153 topics
- Clinical Practice Guidelines92 topics
- Cetuximab71 topic
- KRAS Mutations71 topic
- Endoscopic Resection61 topic
- Gastric Cancer61 topic
- Neoadjuvant Therapy52 topics
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Imatinib Mesylate31 topic
- Lung Tumors31 topic
- Metastatic Carcinomas31 topic
- Preoperative Chemoradiotherapy31 topic
- Rectal Cancer31 topic
- Sunitinib31 topic
- Taxanes31 topic
- Cancer Genomics21 topic
- Mutational Signatures21 topic
- Pancreatic Cancer21 topic
- Surgical Complications21 topic
Where does Gerado Rosati work?
Gerado Rosati's main affiliation in the publication record is Azienda Ospedaliero-Universitaria Careggi, Italy.
How many publications and citations does Gerado Rosati have?
OpenAlex counts 17 works and 72 citations for Gerado Rosati, an h-index of 5, ranking #6,543,847 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gerado Rosati. Posts are plain text and can be reported.